* Sensei Biotherapeutics Inc SNSE.OQ reported a quarterly
adjusted loss of 32 cents per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -33 cents. The mean expectation of
three analysts for the quarter was for a loss of 28 cents per
share. Wall Street expected results to range from -31 cents
to -24 cents per share.
* Reported revenue was zero; analysts expected zero.
* Sensei Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 32 cents.
* The company reported a quarterly loss of $7.99 million.
* Sensei Biotherapeutics Inc shares had risen by 75.2% this
quarter and gained 165.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"
Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $4.00
This summary was machine generated from LSEG data May 9 at 02:51
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.27 -0.32 Missed
Dec. 31 2023 -0.31 -0.30 Beat
Sep. 30 2023 -0.34 -0.28 Beat
Jun. 30 2023 -0.33 -0.31 Beat